U.S. Senators Chuck Grassley, Ron Wyden, and Mike Braun Push FTC To Review Pharmacy Benefit Managers' Role In Insulin Prices
May 23, 2022 - WASHINGTON -- Last week, Sens. Chuck Grassley (R-Iowa), Ron Wyden (D-Ore.) and Mike Braun (R-Ind.) have submitted public comment to the Federal Trade Commission (FTC…
